CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
Etanercept +1 moredrug
Likely dose
Etanercept 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01989689
NCT01989689Phase 2Completed
CompareCT.gov

Etanercept and Vascular Function in Psoriasis

Emory University·interventional·Posted Nov 21, 2013·Updated Dec 19, 2014

In Brief

A Phase 2 clinical trial evaluating Etanercept and Placebo for PSORIASIS. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The investigators plan to measure the health of the vascular system of subjects taking Etanercept for the treatment of plaque psoriasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPSORIASIS
CountriesUnited States
CollaboratorsAmgen

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 21, 2013
Enrollment StartAug 1, 2010
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 12.6 years ago

Interventions

Etanerceptdrug

Etanercept 50mg twice weekly

Placebodrug